LASIK offers good long-term results for high myopes

Article

LASIK for myopia over -10 D is both safe and effective in the long-term.

LASIK for myopia over -10 D is both safe and effective in the long-term, according to a report published in the January issue of the American Journal of Ophthalmology.

Jorge Alio of the Miguel Hernandez University Medical School, Alicante, and of the VISSUM, Instituto Oftalmologico de Alicante, Spain and colleagues from Ankara University of Medicine, Turkey enrolled 196 highly myopic eyes of 118 patients who, preoperatively, required at least 10 D corrections in order to achieve 20/20 vision. All patients were available to follow-up 10 years after initial surgery.

Prior to surgery, uncorrected vision was 77% of best corrected visual acuity (BCVA). Just 5% of eyes lost more than 2 lines BCVA, 40% were able to avoid wearing spectacles and 61% were within ±2 D at 10 years. Only two eyes (1%) developed corneal ectasia.

This study demonstrates that LASIK can offer excellent results in terms of predictability, efficacy and safety for highly myopic patients over the long-term.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.